1968
DOI: 10.1007/bf00599705
|View full text |Cite
|
Sign up to set email alerts
|

Probleme der Chelat-Therapie

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1969
1969
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(3 citation statements)
references
References 14 publications
0
3
0
Order By: Relevance
“…Diethylenetriaminepentaacetic acid (dtpa) is a well‐known chelator that has been used since the 1960s as an agent for treating heavy‐metal poisoning and radioactive contamination 1–3. Its metal complexes are useful tools, one major field of interest being medical imaging.…”
Section: Introductionmentioning
confidence: 99%
“…Diethylenetriaminepentaacetic acid (dtpa) is a well‐known chelator that has been used since the 1960s as an agent for treating heavy‐metal poisoning and radioactive contamination 1–3. Its metal complexes are useful tools, one major field of interest being medical imaging.…”
Section: Introductionmentioning
confidence: 99%
“…DMPS increased the survival of lead-poisoned mice clearly 19 and in rats it caused a substantial elevation of renal lead elimination as well as a reduction of the lead contents of blood, liver, kidney and bones. 3,20,21 In clinical studies with leadintoxicated children lead concentrations decreased also. 22 As shown above, DTPA increased lead uptake without an accompanying increase in lead toxicity.…”
Section: Discussionmentioning
confidence: 99%
“…In previous experiments it was shown that the majority of the employed chelating agents were well tolerated by the cells; a 50% reduction of cell proliferation (IC 50 , 2 d exposure) occurred at > 1 mmol l 21 . The exceptions were MSA, with a slightly elevated IC 50 of 0.1-0.2 mmol l 21 , and DTPA and DDTC with a substantially higher ID 50 of 10-20 mmol l 21 .…”
Section: Chelating Agentsmentioning
confidence: 93%